Save your place

Sign in to WhoBought

Please try again later.

Invesco's Regeneron Pharmaceuticals, Inc. (REGN) position

Yes: as of Q1 2026, Invesco holds 1.7M shares of REGN worth $1.3B (0.2% of the disclosed portfolio). Held since at least Q1 2021; that opening coverage snapshot is not counted as a purchase.
View full portfolio →
Current value
$1.3B
Shares held
1.7M
% of portfolio
0.2%
Est. average buy price (i)
$687.73
est. since Q1 2021
Quarter-end price
$768.97

Estimated trade prices

Average price in quarters with purchases
$743.50
Average prices in quarters with sales
  • Q1 2025: $687.82 (14K shares sold)
  • Q4 2024: $839.22 (297K shares sold)
  • Q2 2024: $969.40 (70K shares sold)
  • Q3 2023: $785.91 (166K shares sold)
  • Q2 2021: $506.62 (11K shares sold)

REGN price vs Invesco's position

1Y 3Y 5Y MAX
Dates
$500$1,000$1,50020222023202420252026Added 26K shares (5.7%) · Q3 2021. Average closing price $620.82 · Price range $574.03–$680.9626KsharespurchasedAdded 104K shares (21.4%) · Q4 2021. Average closing price $614.83 · Price range $543.48–$670.97104KsharespurchasedAdded 15K shares (2.5%) · Q1 2022. Average closing price $632.65 · Price range $595.12–$698.4315KsharespurchasedAdded 25K shares (4.2%) · Q2 2022. Average closing price $650.01 · Price range $548.35–$738.8425KsharespurchasedAdded 13K shares (2.1%) · Q3 2022. Average closing price $629.39 · Price range $573.97–$724.3213KsharespurchasedAdded 52K shares (8.0%) · Q4 2022. Average closing price $737.86 · Price range $705.89–$766.3952KsharespurchasedAdded 192K shares (27.7%) · Q1 2023. Average closing price $754.21 · Price range $680.49–$826.97192KsharespurchasedAdded 24K shares (2.7%) · Q2 2023. Average closing price $771.00 · Price range $700.03–$830.3524KsharespurchasedSold 166K shares (18.2%) · Q3 2023. Average closing price $785.91 · Price range $692.45–$844.37166KsharessoldAdded 22K shares (2.9%) · Q4 2023. Average closing price $823.50 · Price range $775.18–$881.7022KsharespurchasedAdded 221K shares (28.9%) · Q1 2024. Average closing price $950.88 · Price range $902.69–$993.35221KsharespurchasedSold 70K shares (7.1%) · Q2 2024. Average closing price $969.40 · Price range $883.20–$1,071.1970KsharessoldAdded 245K shares (26.7%) · Q3 2024. Average closing price $1,112.86 · Price range $1,024.09–$1,201.76245KsharespurchasedSold 297K shares (25.6%) · Q4 2024. Average closing price $839.22 · Price range $701.85–$1,046.91297KsharessoldSold 14K shares (1.6%) · Q1 2025. Average closing price $687.82 · Price range $634.14–$744.8314KsharessoldAdded 225K shares (26.5%) · Q2 2025. Average closing price $558.13 · Price range $483.07–$625.60225KsharespurchasedAdded 409K shares (38.0%) · Q3 2025. Average closing price $565.41 · Price range $534.91–$598.71409KsharespurchasedAdded 107K shares (7.2%) · Q4 2025. Average closing price $679.43 · Price range $557.73–$787.32107KsharespurchasedAdded 133K shares (8.4%) · Q1 2026. Average closing price $765.64 · Price range $733.04–$812.27133Ksharespurchased← Earlier —1 sell
Average closing price · filing quarter
$765.64
Price range · filing quarter
$733.04 – $812.27
Sign in to see who bought

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 Added +133K +$102M +8.4% 1.7M May 12, 2026
Q4 2025 Added +107K +$72M +7.2% 1.6M Feb 19, 2026
Q3 2025 Added +409K +$231M +38.0% 1.5M Nov 13, 2025
Q2 2025 Added +225K +$126M +26.5% 1.1M Aug 13, 2025
Q1 2025 Reduced −14K −$9.3M −1.6% 851K May 12, 2025
Q4 2024 Reduced −297K −$249M −25.6% 864K Feb 13, 2025
Q3 2024 Added +245K +$272M +26.7% 1.2M Nov 12, 2024
Q2 2024 Reduced −70K −$68M −7.1% 916K Aug 13, 2024
Q1 2024 Added +221K +$210M +28.9% 986K May 14, 2024
Q4 2023 Added +22K +$18M +2.9% 765K Feb 13, 2024
Q3 2023 Reduced −166K −$130M −18.2% 743K Nov 13, 2023
Q2 2023 Added +24K +$19M +2.7% 909K Aug 11, 2023
Q1 2023 Added +192K +$145M +27.7% 885K May 12, 2023
Q4 2022 Added +52K +$38M +8.0% 693K Feb 13, 2023
Q3 2022 Added +13K +$8.3M +2.1% 641K Nov 14, 2022
Q2 2022 Added +25K +$16M +4.2% 628K Aug 15, 2022
Q1 2022 Added +15K +$9.3M +2.5% 603K May 16, 2022
Q4 2021 Added +104K +$64M +21.4% 588K Feb 14, 2022
Q3 2021 Added +26K +$16M +5.7% 484K Nov 15, 2021
Q2 2021 Reduced −11K −$5.5M −2.3% 458K Aug 17, 2021
Q1 2021 First covered – – – 469K May 17, 2021
Data through Q1 2026 · filed May 12, 2026
21 grouped rows from 21 quarters

More Invesco positions

NVIDIA Corporation(NVDA)
$24.7B
3.8% of portfolio

Apple Inc.(AAPL)
$18.4B
2.8% of portfolio

Microsoft Corporation(MSFT)
$15.7B
2.4% of portfolio

Alphabet Inc.(GOOGL)
$12.9B
2.0% of portfolio

Amazon.com, Inc.(AMZN)
$11.8B
1.8% of portfolio

Broadcom Inc.(AVGO)
$10.3B
1.6% of portfolio

Common questions

Does Invesco own REGN?

Yes. As of Q1 2026, Invesco disclosed 1.7M shares of REGN, worth $1.3B. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Invesco buy REGN?

Invesco held REGN since at least Q1 2021, when this filing coverage begins; the opening snapshot is not a disclosed purchase. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Invesco sell REGN?

The quarter-by-quarter table above shows each sale and reduction Invesco disclosed in REGN. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of REGN does Invesco own?

Invesco disclosed 1.7M shares of REGN as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Invesco pay for REGN?

Invesco began building the REGN position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.